|
NAP1L5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.91390000514602E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62470037423645E-12 |
| Stage1-vs-Stage2 |
2.365800E-01 |
| Stage1-vs-Stage3 |
3.554200E-02 |
| Stage1-vs-Stage4 |
6.157100E-03 |
| Stage2-vs-Stage3 |
1.198180E-02 |
| Stage2-vs-Stage4 |
1.318540E-03 |
| Stage3-vs-Stage4 |
2.965600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.656700E-03 |
| Normal-vs-Asian |
2.08639994170312E-10 |
| Caucasian-vs-AfricanAmerican |
4.782200E-02 |
| Caucasian-vs-Asian |
1.014180E-01 |
| AfricanAmerican-vs-Asian |
2.616200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.629700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
2.30315766458489E-12 |
| Normal-vs-Age(81-100Yrs) |
1.558500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.805200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.275000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.054800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.842600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.320000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.86890000031248E-07 |
| Classical-VS-Follicular |
7.00009999965445E-08 |
| Classical-VS-Other |
4.284000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.66133814775094E-15 |
| Tall-VS-Other |
1.080020E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.091600E-02 |
| Follicular-VS-Normal |
2.760600E-04 |
| Other-VS-Normal |
3.85570000005497E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.38631378283117E-13 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.93469999999674E-05 |
|
|
